Fri, Oct 31, 2025
Volume 9, Issue 2 (Spring 2023)
Caspian J Neurol Sci 2023, 9(2): 129-133 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Villoria E, Quintay P, Dela Cruz E, Roxas Jr A. Bilateral Optic Neuritis After Administration of Inactivated COVID-19 Vaccine: A Case Report. Caspian J Neurol Sci 2023; 9 (2) :129-133
URL: http://cjns.gums.ac.ir/article-1-617-en.html
URL: http://cjns.gums.ac.ir/article-1-617-en.html
1- Institute of Neurological Sciences The Medical City, Metro Manila, Philippines
2- University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines
2- University of the East Ramon Magsaysay Memorial Medical Center, Quezon City, Philippines
Abstract: (1494 Views)
Background: Since the beginning of the COVID-19 pandemic, various efforts have been taken to alleviate the spread of the severe acute respiratory syndrome coronavirus 2 (SARS CoV2). Studies have shown effective prevention and protection through vaccination. However, there have also been reports of neurologic diseases after vaccination.
Case Presentation: The first case in the Philippines belonged to a 25-year-old female who initially sought a consult for the increased sleeping time associated with retrograde amnesia immediately after receiving her second dose of inactivated SARS-CoV-2 vaccine. She was then managed as a case of viral encephalitis. However, two weeks later, the patient developed a bilateral decline in visual acuity. Diagnostics included visual perimetry, routine EEG, contrast enhanced cranial MRI, and visual evoked potentials. The patient was then managed as a case of bilateral optic neuritis and was started on pulse methylprednisolone for 3 days with noted gradual but incomplete reversal of the condition.
Conclusion: Autoimmune neurologic events after COVID-19 vaccination are treatable, and the benefits of the vaccination outweigh its risk.
Case Presentation: The first case in the Philippines belonged to a 25-year-old female who initially sought a consult for the increased sleeping time associated with retrograde amnesia immediately after receiving her second dose of inactivated SARS-CoV-2 vaccine. She was then managed as a case of viral encephalitis. However, two weeks later, the patient developed a bilateral decline in visual acuity. Diagnostics included visual perimetry, routine EEG, contrast enhanced cranial MRI, and visual evoked potentials. The patient was then managed as a case of bilateral optic neuritis and was started on pulse methylprednisolone for 3 days with noted gradual but incomplete reversal of the condition.
Conclusion: Autoimmune neurologic events after COVID-19 vaccination are treatable, and the benefits of the vaccination outweigh its risk.
Type of Study: case report |
Subject:
Special
Received: 2023/03/28 | Accepted: 2023/01/11 | Published: 2023/04/23
Received: 2023/03/28 | Accepted: 2023/01/11 | Published: 2023/04/23
| Rights and permissions | |
 | This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |
Copyright © The Author(s);
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC-By-NC), which permits use, distribution, and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
Contact Information
